Delayed
Japan Exchange
09:16:38 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
670
JPY
|
-0.59%
|
|
-0.89%
|
-11.73%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
26,269
|
28,645
|
43,138
|
59,759
|
43,217
|
27,379
|
Enterprise Value (EV)
1 |
28,398
|
30,914
|
44,757
|
60,381
|
42,474
|
26,445
|
P/E ratio
|
18.4
x
|
14.4
x
|
19.9
x
|
35.9
x
|
20.2
x
|
19.3
x
|
Yield
|
0.8%
|
0.83%
|
0.61%
|
0.49%
|
0.73%
|
1.25%
|
Capitalization / Revenue
|
1.77
x
|
1.71
x
|
2.39
x
|
3.57
x
|
2.25
x
|
1.28
x
|
EV / Revenue
|
1.92
x
|
1.85
x
|
2.48
x
|
3.61
x
|
2.21
x
|
1.24
x
|
EV / EBITDA
|
9.28
x
|
9.1
x
|
11.1
x
|
17
x
|
10.4
x
|
7.4
x
|
EV / FCF
|
24.8
x
|
-58.4
x
|
235
x
|
95.1
x
|
113
x
|
2,460
x
|
FCF Yield
|
4.03%
|
-1.71%
|
0.42%
|
1.05%
|
0.88%
|
0.04%
|
Price to Book
|
1.99
x
|
1.89
x
|
2.55
x
|
3.21
x
|
2.02
x
|
1.18
x
|
Nbr of stocks (in thousands)
|
26,401
|
26,401
|
26,384
|
26,384
|
26,384
|
26,301
|
Reference price
2 |
995.0
|
1,085
|
1,635
|
2,265
|
1,638
|
1,041
|
Announcement Date
|
6/25/18
|
6/25/19
|
6/23/20
|
6/22/21
|
6/28/22
|
6/27/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
14,807
|
16,728
|
18,083
|
16,738
|
19,193
|
21,307
|
EBITDA
1 |
3,059
|
3,397
|
4,033
|
3,557
|
4,082
|
3,573
|
EBIT
1 |
2,045
|
2,235
|
2,645
|
2,169
|
2,662
|
2,024
|
Operating Margin
|
13.81%
|
13.36%
|
14.63%
|
12.96%
|
13.87%
|
9.5%
|
Earnings before Tax (EBT)
1 |
1,731
|
2,168
|
2,614
|
2,033
|
2,749
|
1,769
|
Net income
1 |
1,425
|
1,984
|
2,164
|
1,664
|
2,135
|
1,423
|
Net margin
|
9.62%
|
11.86%
|
11.97%
|
9.94%
|
11.12%
|
6.68%
|
EPS
2 |
53.98
|
75.15
|
81.99
|
63.07
|
80.92
|
54.00
|
Free Cash Flow
1 |
1,144
|
-529.1
|
190.1
|
635
|
375
|
10.75
|
FCF margin
|
7.72%
|
-3.16%
|
1.05%
|
3.79%
|
1.95%
|
0.05%
|
FCF Conversion (EBITDA)
|
37.39%
|
-
|
4.71%
|
17.85%
|
9.19%
|
0.3%
|
FCF Conversion (Net income)
|
80.25%
|
-
|
8.79%
|
38.16%
|
17.56%
|
0.76%
|
Dividend per Share
2 |
8.000
|
9.000
|
10.00
|
11.00
|
12.00
|
13.00
|
Announcement Date
|
6/25/18
|
6/25/19
|
6/23/20
|
6/22/21
|
6/28/22
|
6/27/23
|
Fiscal Period: March |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Net sales
1 |
8,782
|
9,301
|
7,753
|
8,985
|
4,321
|
8,858
|
5,120
|
5,215
|
10,335
|
5,027
|
4,962
|
9,989
|
5,635
|
5,683
|
11,318
|
5,403
|
10,952
|
6,041
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
1,266
|
1,378
|
823
|
1,345
|
504
|
1,058
|
933
|
670
|
1,603
|
498
|
429
|
927
|
583
|
514
|
1,097
|
346.4
|
617
|
566
|
Operating Margin
|
14.42%
|
14.82%
|
10.62%
|
14.97%
|
11.66%
|
11.94%
|
18.22%
|
12.85%
|
15.51%
|
9.91%
|
8.65%
|
9.28%
|
10.35%
|
9.04%
|
9.69%
|
6.41%
|
5.63%
|
9.37%
|
Earnings before Tax (EBT)
1 |
1,275
|
-
|
788
|
-
|
-
|
1,326
|
872
|
-
|
-
|
478
|
-
|
932
|
608
|
-
|
-
|
253
|
539
|
582
|
Net income
1 |
922
|
1,242
|
526
|
1,138
|
640
|
1,003
|
631
|
501
|
1,132
|
336
|
385
|
721
|
417
|
285
|
702
|
177.3
|
359
|
373
|
Net margin
|
10.5%
|
13.35%
|
6.78%
|
12.67%
|
14.81%
|
11.32%
|
12.32%
|
9.61%
|
10.95%
|
6.68%
|
7.76%
|
7.22%
|
7.4%
|
5.01%
|
6.2%
|
3.28%
|
3.28%
|
6.17%
|
EPS
2 |
34.93
|
-
|
19.95
|
-
|
-
|
38.03
|
23.92
|
-
|
-
|
12.75
|
-
|
27.35
|
15.85
|
-
|
-
|
6.740
|
13.67
|
14.18
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/31/19
|
4/30/20
|
10/30/20
|
4/30/21
|
10/29/21
|
10/29/21
|
1/31/22
|
4/28/22
|
4/28/22
|
7/29/22
|
10/31/22
|
10/31/22
|
1/31/23
|
4/28/23
|
4/28/23
|
7/28/23
|
10/30/23
|
1/31/24
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,129
|
2,269
|
1,619
|
622
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
743
|
934
|
Leverage (Debt/EBITDA)
|
0.696
x
|
0.6679
x
|
0.4014
x
|
0.1749
x
|
-
|
-
|
Free Cash Flow
1 |
1,144
|
-529
|
190
|
635
|
375
|
10.8
|
ROE (net income / shareholders' equity)
|
11.2%
|
14%
|
13.6%
|
9.41%
|
10.7%
|
6.41%
|
ROA (Net income/ Total Assets)
|
6.03%
|
6.3%
|
6.83%
|
5.41%
|
6.33%
|
4.46%
|
Assets
1 |
23,640
|
31,504
|
31,685
|
30,755
|
33,708
|
31,934
|
Book Value Per Share
2 |
501.0
|
575.0
|
642.0
|
706.0
|
811.0
|
881.0
|
Cash Flow per Share
2 |
93.10
|
85.60
|
95.20
|
93.50
|
98.20
|
107.0
|
Capex
1 |
1,001
|
1,977
|
1,654
|
1,348
|
1,539
|
1,222
|
Capex / Sales
|
6.76%
|
11.82%
|
9.15%
|
8.05%
|
8.02%
|
5.74%
|
Announcement Date
|
6/25/18
|
6/25/19
|
6/23/20
|
6/22/21
|
6/28/22
|
6/27/23
|
|
1st Jan change
|
Capi.
|
---|
| -11.73% | 113M | | -3.54% | 9.4B | | +31.91% | 1.92B | | -2.55% | 1.39B | | -5.98% | 1.18B | | -16.69% | 856M | | +0.53% | 470M | | +3.39% | 437M | | -47.20% | 360M | | -22.36% | 333M |
Medical Equipment Wholesale
|